BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

EFECON® Becomes First Approved Therapy for IgAN in China, Offering Hope to Millions with Improved Patient Care and Disease Management

Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines ...

May 15, 2024 | News

Touchlight Genetics and NPL Receive Innovate UK Funding for Advanced Gene Therapy Technology

Touchlight Genetics, in partnership with the National Physical Laboratory (NPL) have secured funding from Innovate UK under their Innovative Technologies: ...

May 13, 2024 | News

ImmunityBio, Serum Institute of India Agree on an Exclusive Arrangement for Global Supply of Bacillus Calmette-Guerin (BCG) Across All Cancer Types

The agreement aims to supply ImmunityBio with Bacillus Calmette-Guerin (BCG), a critical component in cancer treatment. Under the collaboration, the ...

May 06, 2024 | News

Agilent Introduces NovoCyte Opteon Spectral Flow Cytometer, Redefining Flow Cytometry Standards

Agilent has announced the NovoCyte Opteon Spectral Flow Cytometer, propelling flow cytometry into a new era of and accessibility. This cutting-edge system ...

May 06, 2024 | News

ImmunityBio and Serum Institute of India Secure Global BCG Supply Agreement for Cancer Treatment

Collaboration will result in BCG manufacture at large scale for use in combination with ANKTIVA®, ImmunityBio’s recently approved treatme...

May 03, 2024 | News

AstraZeneca Highlights Key Respiratory and Immune Research at ATS 2024

AstraZeneca will present new clinical and real-world data from its expansive respiratory portfolio at the American Thoracic Society (ATS) International Con...

May 02, 2024 | News

WuXi AppTec Reports First Quarter 2024 Financial Results: Solid Performance with Continued Growth in R&D Services

First Quarter 2024 Financial Highlights: Revenue of RMB 7,982 million, with a slight decrease of 1.8% in non-COVID-19 commercial projects, underscoring ...

April 30, 2024 | Company results

PRISM BioLab and ONO Pharmaceutical Forge Strategic Collaboration to Advance Oncology Drug Development

PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein int...

April 26, 2024 | News

GenFleet Therapeutics Secures FDA Approval for Pioneering Phase III KRAS G12C Inhibitor Trial in Colorectal Cancer

GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Adm...

April 22, 2024 | News

Teva Validates AJOVY® Efficacy and Safety in China Phase 3 Migraine Trial

AJOVY confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month All critical efficacy endpoints met significanc...

April 15, 2024 | News

NTT Research Foundation Establishes Pioneering Fellowship Program at Harvard to Explore the Physics of Intelligence

NTT Research Foundation funds Fellowship Program in new field of Physics of Intelligence. Field of study bridges computer science, brain science and phy...

April 12, 2024 | News

ACROBiosystems Debuts 3D Organoid Solutions for Biotherapeutic Research

ACROBiosystems has been continuously rolling out a series of innovative organoid-related products. At a range of significant international events, includin...

April 11, 2024 | News

Cure Brain Cancer Foundation Launches Pioneering $575,000 Fellowship to Support Emerging Leaders in Brain Cancer Research

Cure Brain Cancer Foundation proudly unveiled the launch of its groundbreaking 5-Year Guardian Trust Early Career Fellowship, valued at $575,000. The...

April 08, 2024 | News

Grindeks Expands Global Footprint with New Subsidiaries and Innovative Product Pipeline

In a strategic move to broaden its international market presence, Grindeks has successfully established 28 subsidiaries across Eu...

April 03, 2024 | News

Stay Connected